Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma’s Approach, Part 1
Authors:
Open Access
- 1 September 2014
- journal article
- research article
- Published by Springer Nature in Therapeutic Innovation & Regulatory Science
- Vol. 48 (5) , 529-535
Abstract
Central monitoring, on-site monitoring, and off-site monitoring provide an integrated approach to clinical trial quality management. TransCelerate distinguishes central monitoring from other types of central data review activities and puts it in the context of an overall monitoring strategy. Any organization seeking to implement central monitoring will need people with the right skills, technology options that support a holistic review of study-related information, and adaptable processes. There are different approaches actively being used to implement central monitoring. This article provides a description of how companies are deploying central monitoring, as well as samples of the workflows that illustrate how some have implemented it. The desired outcomes include earlier, more predictive detection of quality issues. This paper describes the initial implementation steps designed to learn what organizational capabilities are necessary.Keywords
This publication has 4 references indexed in Scilit:
- Technology Considerations to Enable the Risk-Based Monitoring MethodologyTherapeutic Innovation & Regulatory Science, 2014
- Application of methods for central statistical monitoring in clinical trialsClinical Trials, 2013
- A statistical approach to central monitoring of data quality in clinical trialsClinical Trials, 2012
- The role of biostatistics in the prevention, detection and treatment of fraud in clinical trialsStatistics in Medicine, 1999